Differential effects of vigabatrin and zonisamide on the neuropeptide Y system in the hippocampus of seizure prone gerbil

Neuropeptides

Volumn 39, Issue 5, 2005, Pages 507-513

  Kwak, Sung Eun ^a   Kim, Ji Eun ^a   Kim, Duk Soo ^a   Won, Moo Ho ^a   Choi, Hui Chul ^a   Kim, Yeong In ^b   Song, Hong Ki ^a   Choi, Soo Young ^a   Kang, Tae Cheon ^a  

^a Hallym University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Epilepsy; Gerbil; Hippocampus; Neuropeptide Y; Vigabatrin; Zonisamide

Indexed keywords

MESSENGER RNA; NEUROPEPTIDE Y; SODIUM CHLORIDE; VIGABATRIN; ZONISAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; COMPARATIVE STUDY; CONTROLLED STUDY; DENSITY; DENTATE GYRUS; DOSE RESPONSE; GENE EXPRESSION; GERBIL; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; NERVE CELL; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ANTICONVULSANTS; GERBILLINAE; HIPPOCAMPUS; IN SITU HYBRIDIZATION; ISOXAZOLES; NEUROPEPTIDE Y; SEIZURES; VIGABATRIN;

ANIMALIA; GERBILLINAE;

EID: 26644459963     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2005.08.003     Document Type: Article

References (32)

1. J.A. Armijo, R. Arteaga, E.M. Valdizan, and J.L. Herranz Coadministration of vigabatrin and valproate in children with refractory epilepsy Clin. Neuropharmacol. 15 1992 459 469
2. H.E. Bays Current and investigational antiobesity agents and obesity therapeutic treatment targets Obes. Res. 12 2004 1197 1211
3. W.F. Colmers, and B. El Bahh Neuropeptide Y and epilepsy Epilepsy Curr. 2 2003 53 58
4. S. DePrato Primeaux, P.V. Holmes, R.J. Martin, R.G. Dean, and G.L. Edwards Experimentally induced attenuation of neuropeptide-Y gene expression in transgenic mice increases mortality rate following seizures Neurosci. Lett. 287 2000 61 64
5. K. Fukui, Y. Kawashima, H. Iizumi, H. Utsumi, and T. Nakajima Immunohistochemical alterations in neuropeptide Y-positive nerve elements in rat cerebral cortex following acute phencyclidine treatment Neuroreport 6 1995 626 628
6. K. Fukui, Y. Kawashima, H. Iizumi, H. Utsumi, and T. Nakajima The effects of acute phencyclidine treatment on neuropeptide Y (NPY) neuronal system in the rat arcuate nucleus studied by immunocytochemistry and in situ hybridization J. Neural Transm. 103 1996 385 390
7. D.R. Gehlert Role of hypothalamic neuropeptide Y in feeding and obesity Neuropeptides 33 1999 329 338
8. D.R. Gehlert, and P.A. Hipskind Neuropeptide Y receptor antagonists in obesity Expert Opin. Inves. Drugs 6 1997 1827 1838
9. E.E. Geisert Jr., R.W. Williams, G.R. Geisert, L. Fan, A.M. Asbury, H.T. Maecker, J. Deng, and S. Levy Increased brain size and glial cell number in CD81-null mice J. Comp. Neurol. 453 2002 22 32
10. S. Geuna Appreciating the difference between design-based and model-based sampling strategies in quantitative morphology of the nervous system J. Comp. Neurol. 427 2000 333 339
11. L. Gram, O.M. Larsson, A.H. Johnsen, and A. Schousboe Effects of valproate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons Epilepsy Res. 2 1988 87 95
12. H. Husum, S.H. Gruber, T.G. Bolwig, and A.A. Mathe Extracellular levels of NPY in the dorsal hippocampus of freely moving rats are markedly elevated following a single electroconvulsive stimulation, irrespective of anticonvulsive Y1 receptor blockade Neuropeptides 36 2002 363 369
13. B.H. Hwang, R. Suzuki, L. Lumeng, T.K. Li, and W.J. McBride Innate differences in neuropeptide Y (NPY) mRNA expression in discrete brain regions between alcohol-preferring (P) and -nonpreferring (NP) rats: a significantly low level of NPY mRNA in dentate gyrus of the hippocampus and absence of NPY mRNA in the medial habenular nucleus of P rats Neuropeptides 38 2004 359 368
14. p. Jallon, and F. Picard Bodyweight gain and anticonvulsants: a comparative review Drug Saf. 24 2001 969 978
15. T.C. Kang, S.H. Park, S.K. Park, J.C. Lee, S.M. Jo, S.G. Do, J.G. Suh, Y.S. Oh, J.Y. Lee, and M.H. Won The temporal and spatial expressions of neuropeptide Y induced by seizure in the hippocampal complex of gerbil Brain Res. 870 2000 179 184
16. T.C. Kang, S.K. Park, S.G. Do, J.G. Suh, S.M. Jo, Y.S. Oh, Y.G. Jeong, and M.H. Won The over-expression of somatostatin in the gerbil entorhinal cortex induced by seizure Brain Res. 882 2000 55 61
17. T.C. Kang, S.K. Park, I.K. Hwang, S.J. An, S.Y. Choi, O.S. Kwon, N.I. Baek, H.Y. Lee, and M.H. Won The altered expression of GABA shunt enzymes in the gerbil hippocampus before and after seizure generation Neurochem. Int. 42 2003 239 249
18. T.C. Kang, S.J. An, S.K. Park, I.K. Hwang, J.C. Bae, and M.H. Won Changed vesicular GABA transporter immunoreactivity in the gerbil hippocampus following spontaneous seizure and vigabatrin administration Neurosci. Lett. 335 2003 207 211
19. T.C. Kang, S.J. An, S.K. Park, I.K. Hwang, and M.H. Won P2X2 and P2X4 receptor expression is regulated by a GABA(A) receptor-mediated mechanism in the gerbil hippocampus Mol. Brain Res. 116 2003 168 175
20. T.C. Kang, S.J. An, S.K. Park, I.K. Hwang, S.Y. Choi, O.S. Kwon, and M.H. Won Effect of vigabatrin on glutamate dehydrogenase in the hippocampus of seizure prone gerbils Neurosci. Lett. 340 2003 115 118
21. S.E. Kwak, J.E. Kim, D.S. Kim, J.Y. Jung, M.H. Won, O.S. Kwon, S.Y. Choi, and T.C. Kang Effects of GABAergic transmissions on the immunoreactivities of calcium binding proteins in the gerbil hippocampus J. Comp. Neurol. 485 2005 153 164
22. W. Loscher, and D. Horstermann Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma Naunyn-Schmiedeberg's Arch. Pharmacol. 349 1994 270 278
23. W.J. Loskota, P. Lomax, and S.T. Rich The gerbil as a model for the study of the epilepsies. Seizure patterns and ontogenesis Epilepsia 15 1974 109 119
24. L.P. Midgley, L.G. Bush, J.W. Gibb, and G.R. Hanson Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen Brain Res. 593 1992 89 96
25. L.P. Midgley, L.G. Bush, J.W. Gibb, and G.R. Hanson Differential regulation of neuropeptide Y systems in limbic structures of the rat J. Pharmacol. Exp. Therap. 267 1993 707 713
26. +, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode Brit. J. Pharmacol. 124 1998 1277 1285
27. A.J. Owen, S. Ijaz, H. Miyashita, T. Wishart, W. Howlett, and A. Shuaib Zonisamide as a neuroprotective agent in an adult gerbil model of global forebrain ischemia: a histological, in vivo microdialysis and behavioral study Brain Res. 770 1997 115 122
28. D. Parker, C. Soderberg, E. Zotova, O. Shupliakov, U. Langel, T. Bartfai, D. Larhammar, L. Brodin, and S. Grillner Co-localized neuropeptide Y and GABA have complementary presynaptic effects on sensory synaptic transmission Eur. J. Neurosci. 10 1998 2856 2870
29. L.A. Paul, I. Fried, K. Watanabe, A.B. Forsythe, and A.B. Scheibel Structural correlates of seizure behavior in the mongolian gerbil Science 213 1981 924 926
30. N.E. Preece, and S. Cerdan Metabolic precursors and compartmentation of cerebral GABA in vigabatrin-treated rats J. Neurochem. 67 1996 1718 1725
31. M. Qume, and L.J. Fowler Effects of chronic oral treatment with GABA-transaminase inhibitors on the GABA system in brain, liver, kidney, and plasma of the rat Biochem. Pharmacol. 52 1996 1355 1363
32. J. Wilding Clinical evaluation of anti-obesity drugs Curr. Drug Targets 5 2004 325 332